1st GS	First-Generation Sequencing
ALL	Acute Lymphoblastic Leukemia
Allo-HSCT	Allogeneic Hematopoietic Stem Cell
BMT	Blood and Marrow Transplant
CAR	Chimeric Antigen Receptor
cART	Combined Anti-Retroviral Therapy
CGH	Comparative Genomic Hybridization
CML	Chronic Myeloid Leukemia
CNB	Core Needle Biopsy
CT	Computed Tomography
CTLA-4	Cytotoxic T-Lymphocyte-Associated Protein 4
DSP	Digital Spatial Profiling
EFS	Event-Free Survival
EGF	Epidermal Growth Factor
EGFR	Epidermal Growth Factor Receptor
FISH	Fluorescence in Situ Hybridization
FMRI	Functional Magnetic Resonance Imaging
FNAC	Fine Needle Aspiration Cytology
GvHD	Graft-versus-Host Disease
HER2	Human Epidermal Growth Factor Receptor 2
ICI	Immune Checkpoint Inhibitors
IFN-α	Interferon-α
IHC	Immunohistochemistry
IMC	Imaging Mass Cytometry
irAEs	Immune-related Adverse Events
ISH	In Situ Hybridization
MIBI	Multiplexed Ion Beam Imaging
mIHC	Multiplex IHC
NET	Neuroendocrine Tumor
NGS	Next/Second-Generation Sequencing
ORR	Overall Response Rate
OS	Overall Survival
PARP	Poly (ADP-ribose) Polymerase
PD-1	Programmed Cell Death Protein 1
PDGFR	Platelet-derived Growth Factor Receptor
PD-L1	Programmed Cell Death Protein 1 Ligand
PET	Positron Emission Tomography
PFS	Progression-free Survival
Poly-ICLC	Polyinosinic-Polycytidylic Acid with Poly-L-lysine and Carboxymethylcellulose
PRRT	Peptide Receptor Radionuclide Therapy
SBRT	Stereotactic Body Radiation Therapy
SIRT	Selective Internal Radiation Therapy
SNP	Single Nucleotide Polymorphisms
SSTR	Somatostatin Receptor
TKI	Tyrosine Kinase Inhibitor
TKIs	Tyrosine Kinase Inhibitors
USC	Uterine Serous Carcinomas
VATS	Video-Assisted Thoracoscopic Surgery
VEGF	Vascular Endothelial Growth Factor
VEGFR	Vascular Endothelial Growth Factor Receptor
WGS	Whole Genome Sequencing